Durogesic DTrans in children

The prescribing information for Durogesic DTrans (fentanyl) transdermal patch has been updated to include new information about use in paediatric patients.

Durogesic DTrans patches can be used in opioid-tolerant patients aged two to 16 years who are already receiving at least 30mg oral morphine equivalent per day. Patches should be applied to the upper back to minimise the chances of the child removing them and patch adhesion should be monitored closely.

New warnings state that the product must not be administered in opioid-naïve children, and the potential for serious or life-threatening hypoventilation exists regardless of the dose.

Further information: Janssen-Cilag 01494 567444

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more